BR9809333A - Inibidores de proteases - Google Patents
Inibidores de proteasesInfo
- Publication number
- BR9809333A BR9809333A BR9809333-9A BR9809333A BR9809333A BR 9809333 A BR9809333 A BR 9809333A BR 9809333 A BR9809333 A BR 9809333A BR 9809333 A BR9809333 A BR 9809333A
- Authority
- BR
- Brazil
- Prior art keywords
- disease
- protease inhibitors
- compounds
- arthritis
- oesteoarthritis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4506797P | 1997-04-29 | 1997-04-29 | |
PCT/US1998/008740 WO1998048799A1 (fr) | 1997-04-29 | 1998-04-29 | Inhibiteurs de proteases |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9809333A true BR9809333A (pt) | 2000-07-04 |
Family
ID=21935831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9809333-9A BR9809333A (pt) | 1997-04-29 | 1998-04-29 | Inibidores de proteases |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1019046A4 (fr) |
JP (1) | JP2002504097A (fr) |
KR (1) | KR20010020391A (fr) |
CN (1) | CN1261276A (fr) |
AR (1) | AR012622A1 (fr) |
AU (1) | AU7365198A (fr) |
BR (1) | BR9809333A (fr) |
CA (1) | CA2287989A1 (fr) |
CO (1) | CO4940477A1 (fr) |
HU (1) | HUP0001294A3 (fr) |
IL (1) | IL132629A0 (fr) |
MA (1) | MA26487A1 (fr) |
NO (1) | NO995268L (fr) |
PE (1) | PE69099A1 (fr) |
PL (1) | PL337725A1 (fr) |
TR (1) | TR199902703T2 (fr) |
WO (1) | WO1998048799A1 (fr) |
ZA (1) | ZA983522B (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1924699A (en) | 1997-12-19 | 1999-07-12 | Smithkline Beecham Corporation | Compounds of heteroaryl substituted imidazole, their pharmaceutical compositionsand uses |
US6100282A (en) * | 1998-01-02 | 2000-08-08 | Hoffman-La Roche Inc. | Thiazole derivatives |
MA26618A1 (fr) * | 1998-04-09 | 2004-12-20 | Smithkline Beecham Corp | Composes et compositions pharmaceutiques pour le traitement du paludisme |
US6858617B2 (en) | 1998-05-26 | 2005-02-22 | Smithkline Beecham Corporation | Substituted imidazole compounds |
ATE258055T1 (de) | 1998-11-04 | 2004-02-15 | Smithkline Beecham Corp | Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine |
CO5150165A1 (es) * | 1998-11-13 | 2002-04-29 | Smithkline Beecham Plc | Inhibidores de proteasa: tipo catepsina k |
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
AU1588901A (en) | 1999-11-10 | 2001-06-06 | Smithkline Beecham Corporation | Protease inhibitors |
EP1232154A4 (fr) | 1999-11-10 | 2004-06-23 | Smithkline Beecham Corp | Inhibiteurs de protease |
JP2003513924A (ja) | 1999-11-10 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | プロテア−ゼ阻害剤 |
US6797720B2 (en) | 1999-12-03 | 2004-09-28 | Ono Pharmaceutical Co., Ltd. | 1,3,4-oxadiazoline derivative and an agent comprising its derivative as active ingredient |
KR20020062312A (ko) * | 1999-12-03 | 2002-07-25 | 오노 야꾸힝 고교 가부시키가이샤 | 1,3,4-옥사디아졸린 유도체 및 이들을 유효 성분으로하는 약제 |
CZ20023168A3 (cs) | 2000-03-21 | 2003-02-12 | Smithkline Beecham Corporation | Inhibitory proteázy |
EP1465862A1 (fr) | 2002-01-17 | 2004-10-13 | SmithKline Beecham Corporation | Derives de cetoamides a substitution cycloalkyle, utiles comme inhibiteurs de cathepsine k |
DE60227008D1 (de) * | 2002-07-04 | 2008-07-17 | Aventis Pharma Sa | Neue thiophenacylhydrazinoderivate, verfahren zu deren herstellung, deren verwendung als arzneimittel, pharmazeutische zusammensetzungen und neue anwendungen |
KR100962972B1 (ko) | 2002-07-26 | 2010-06-09 | 주식회사유한양행 | 1-페닐피페리딘-3-온 유도체 및 그의 제조방법 |
WO2011015524A2 (fr) * | 2009-08-03 | 2011-02-10 | Bayer Cropscience Ag | Dérivés dhétérocycles fongicides |
JP6243908B2 (ja) * | 2012-08-23 | 2017-12-06 | アリオス バイオファーマ インク. | パラミクソウイルス感染症を治療するための化合物 |
JP6485817B2 (ja) | 2013-08-21 | 2019-03-20 | ヤンセン バイオファーマ インク. | 抗ウイルス化合物 |
MA41614A (fr) | 2015-02-25 | 2018-01-02 | Alios Biopharma Inc | Composés antiviraux |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ132798A3 (cs) * | 1995-10-30 | 1999-02-17 | Smithkline Beecham Corporation | Inhibitory proteázy |
-
1998
- 1998-04-24 MA MA25047A patent/MA26487A1/fr unknown
- 1998-04-27 PE PE1998000320A patent/PE69099A1/es not_active Application Discontinuation
- 1998-04-28 ZA ZA983522A patent/ZA983522B/xx unknown
- 1998-04-29 JP JP54738998A patent/JP2002504097A/ja active Pending
- 1998-04-29 TR TR1999/02703T patent/TR199902703T2/xx unknown
- 1998-04-29 BR BR9809333-9A patent/BR9809333A/pt not_active IP Right Cessation
- 1998-04-29 IL IL13262998A patent/IL132629A0/xx unknown
- 1998-04-29 AU AU73651/98A patent/AU7365198A/en not_active Abandoned
- 1998-04-29 EP EP98920926A patent/EP1019046A4/fr not_active Withdrawn
- 1998-04-29 CO CO98023491A patent/CO4940477A1/es unknown
- 1998-04-29 CN CN98806641A patent/CN1261276A/zh active Pending
- 1998-04-29 PL PL98337725A patent/PL337725A1/xx unknown
- 1998-04-29 HU HU0001294A patent/HUP0001294A3/hu unknown
- 1998-04-29 KR KR1019997010013A patent/KR20010020391A/ko not_active Application Discontinuation
- 1998-04-29 CA CA002287989A patent/CA2287989A1/fr not_active Abandoned
- 1998-04-29 WO PCT/US1998/008740 patent/WO1998048799A1/fr not_active Application Discontinuation
- 1998-04-29 AR ARP980101999A patent/AR012622A1/es unknown
-
1999
- 1999-10-28 NO NO995268A patent/NO995268L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL337725A1 (en) | 2000-08-28 |
EP1019046A1 (fr) | 2000-07-19 |
CN1261276A (zh) | 2000-07-26 |
CO4940477A1 (es) | 2000-07-24 |
HUP0001294A3 (en) | 2001-06-28 |
EP1019046A4 (fr) | 2002-11-27 |
HUP0001294A2 (hu) | 2001-04-28 |
TR199902703T2 (xx) | 2000-02-21 |
WO1998048799A1 (fr) | 1998-11-05 |
CA2287989A1 (fr) | 1998-11-05 |
PE69099A1 (es) | 1999-09-26 |
IL132629A0 (en) | 2001-03-19 |
NO995268D0 (no) | 1999-10-28 |
ZA983522B (en) | 1998-10-29 |
MA26487A1 (fr) | 2004-12-20 |
NO995268L (no) | 1999-11-15 |
AR012622A1 (es) | 2000-11-08 |
KR20010020391A (ko) | 2001-03-15 |
AU7365198A (en) | 1998-11-24 |
JP2002504097A (ja) | 2002-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9809333A (pt) | Inibidores de proteases | |
AP9801222A0 (en) | Proatease inhibitors. | |
NO20013124D0 (no) | Protease inhibitorer | |
BR0109356A (pt) | Inibidores de protease | |
NZ537853A (en) | Inhibitors of cathepsin K and related cysteine protesases of the CA clan | |
BR9804437A (pt) | Compostos para a osteoporose | |
BR9815469A (pt) | Inibidores de protease | |
WO1999059526A3 (fr) | Inhibiteurs de protease | |
EA200300018A1 (ru) | Ингибиторы протеаз | |
UY26088A1 (es) | Inhibidores de proteasas | |
UY26026A1 (es) | Inhibidores de proteasas | |
WO2002092563A3 (fr) | Inhibiteurs de protease | |
PT640098E (pt) | Gene de coronavirus canino e suas utilizacoesc | |
UY27032A1 (es) | Inhibidores de proteasas | |
NZ324101A (en) | Protease inhibitors, pharmaceutical compositions and use thereof | |
ECSP982481A (es) | Inhibidores de proteasas | |
ECSP982486A (es) | Inhibidores de proteasas ii | |
AR004703A1 (es) | Hidrazidil, bis-hidrazil y bis-aminometil-carbonil, inhibidores de proteasas, una composicin farmaceutica, metodo para inhibir proteasas, y uso en la preparacion de medicamentos. | |
ECSP003403A (es) | Inhibidores de proteasas xi | |
ECSP982493A (es) | Inhibidores de proteasas iii | |
ECSP992959A (es) | Inhibidores de proteasa de bis- aminometil carbonilo | |
AR021971A1 (es) | Inhibidores de proteasas | |
UY24550A1 (es) | Inhibidores de proteasa | |
ECSP993293A (es) | Inhibidores de proteasas viii | |
UY26771A1 (es) | Inhibidores de proteasas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A, 7A, 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1889 DE 20/03/2007. |